Markets:

Overview

News

Currencies

International

Treasuries

Cara Therapeutics, Inc. - Common Stock (NQ:CARA)

5.320 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cara Therapeutics, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

Cannabis Stock Movers For March 14, 2022 ↗

March 14, 2022

GAINERS: Leviathan Natural Prods (OTC:

Via Benzinga

Marijuana Stock Movers For March 9, 2022 ↗

March 09, 2022

GAINERS: MGC Pharmaceuticals (OTC:

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers ↗

March 08, 2022

GAINERS: Nine Energy Service (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022 ↗

March 08, 2022

Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...

Via Benzinga

Cara Therapeutics To Host Virtual R&D On March 11 ↗

February 18, 2022

Cara Therapeutics, (NASDAQ:CARA) ...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

March 08, 2022

Raymond James cut the price target on Ciena Corporation (NYSE: CIEN) from $80 to $75. Ciena shares fell 10.9% to close at $58.76 on Monday. Telsey Advisory Group cut Capri...

Via Benzinga

Looking Into Cara Therapeutics's Return On Capital Employed ↗

March 03, 2022

Benzinga Pro data, Cara Therapeutics (NASDAQ:CARA) reported Q4 sales of $821.00 thousand. Earnings fell to a loss of $33.38 million, resulting in a 3195.36% decrease from last...

Via Benzinga

Cara Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results ↗

March 01, 2022

Cara Therapeutics, Inc. (NASDAQ:CARA), an early commercial...

Via Benzinga

Recap: Cara Therapeutics Q4 Earnings ↗

March 01, 2022

Cara Therapeutics (NASDAQ:CARA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

Cannabis Stock Gainers And Losers From February 2, 2022 ↗

February 02, 2022

GAINERS: Item 9 Labs (OTC:INLB) shares closed up 7.14% at $1.20

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 10, 2022

On Thursday, 89 companies hit new 52-week lows. Noteable 52-Week Lows: The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:SGEN)....

Via Benzinga

Cannabis Stock Gainers And Losers From January 31, 2022 ↗

January 31, 2022

GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76

Via Benzinga

Cannabis Stock Gainers And Losers From January 27, 2022 ↗

January 27, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03

Via Benzinga

Cannabis Stock Gainers And Losers From January 26, 2022 ↗

January 26, 2022

GAINERS: Item 9 Labs (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 19, 2022 ↗

January 19, 2022

GAINERS: Heritage Cannabis Holding (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 18, 2022 ↗

January 18, 2022

GAINERS: Item 9 Labs (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 5, 2022 ↗

January 05, 2022

GAINERS: Rhinomed (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 3, 2022 ↗

January 03, 2022

GAINERS: BioHarvest Sciences (OTC:

Via Benzinga

Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack ↗

December 14, 2021

Photo by Michael Longmire on...

Via Benzinga

XPO Logistics (Formerly Segmentz) Founder and Grove Inc (GRVI) CEO Brings Deep Experience in Growing Companies ↗

November 10, 2021

Image Provided By Pixabay The following post was...

Via Benzinga

Cara Therapeutics, inc (CARA) Q3 2021 Earnings Call Transcript ↗

November 08, 2021

CARA earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

3 Explosive Biotech Stocks -- Could They Shoot Even Higher? ↗

November 03, 2021

These biotech stocks have recently been responsible for a slew of rocketship emojis.

Via The Motley Fool

Is Cara Therapeutics Stock a Buy After Its First FDA Drug Approval ↗

September 04, 2021

There's good news at long last for the beaten-down biotech stock.

Via The Motley Fool

64 Biggest Movers From Yesterday ↗

October 28, 2021

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates ↗

August 31, 2021

August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New...

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 25, 2021

Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...

Via Benzinga

Why Cara Therapeutics Shot Higher Today ↗

August 24, 2021

The biotech gets an important nod from a top regulator.

Via The Motley Fool

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.